Peng Liu

34PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityNeural engineeringMolecular targetsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 15, 2026
A chemical-genetic system for calreticulin exposure on cancer cells reveals immune-dependent antitumor effects.

|May 03, 2026
The autophagy-inhibitory tissue hormone DBI/ACBP is essential for glucocorticoid-induced immunosuppression.

|Apr 10, 2026
Restoring dendritic cell migration: a gut reaction to boost vaccine efficacy in aging.

Liwei Zhao, Oliver Kepp, Guido Kroemer

|Mar 09, 2026
KRAS-elicited PDIA6 blocks PERK-dependent immunogenic cell death in pancreatic carcinoma.

Liwei Zhao, Peng Liu, Guido Kroemer

|Mar 04, 2026
Neutralization of acyl-CoA-binding protein attenuates glucocorticoid-mediated suppression of cancer immunosurveillance.

Hui Pan, Zhe Shen, Liwei Zhao

|Jul 12, 2025
How macrophages use extracellular calreticulin to chase their prey.

Liwei Zhao, Peng Liu, Oliver Kepp

Pageof 6

Frequent Collaborators

27 joint publications

Oliver Kepp

25 joint publications

Guido Kroemer

13 joint publications

Liwei Zhao

7 joint publications

Laurence Zitvogel